Follow-up and Steroid Treatment Results in Intussusception
Launched by BASKENT UNIVERSITY · Nov 29, 2022
Trial Information
Current as of January 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how well a single dose of steroids can help treat intussusception, a condition where part of the intestine folds into itself, causing blockages. The researchers want to see if using steroids can reduce inflammation and potentially allow the intestine to return to its normal state without the need for more invasive treatments, like surgery. They have found that in some cases, patients have experienced improvement just by monitoring their condition with steroids, which could make treatment safer and less stressful for children.
To participate in this study, children aged between a few weeks to several years who have been diagnosed with intussusception at Başkent University Ankara Hospital may be eligible. Key requirements include having a diagnosis confirmed by an ultrasound and needing to consult with pediatric surgery. Families will be fully informed about the treatment options and will need to provide consent for their child to take part. Throughout the trial, participants will be closely monitored, and the hope is that this approach will help avoid the risks associated with other treatments, like infection or surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • who applied to Başkent University Ankara Hospital Pediatric Emergency Polyclinic,
- • Diagnosed with intussusception by USG,
- • Consulted with Pediatric Surgery
- • Informed consent was obtained by explaining treatment options to their families.
- Exclusion Criteria:
- • Diffuse tenderness and defense on abdominal examination,
- • The duration of the complaints exceeds 24 hours,
- • When the intestinal blood supply is decreased in the ultrasound findings,
- • Patients with free air on the standing abdominal X-ray,
- • Patients with pathology requiring urgent surgical intervention
Trial Officials
Ender Fakıoğlu
Principal Investigator
Baskent Univesity
About Baskent University
Baskent University is a distinguished academic and research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on evidence-based medicine, the university collaborates with a network of healthcare professionals and researchers to design and implement rigorous clinical research that aims to improve patient outcomes. Baskent University is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while fostering a collaborative environment that promotes scientific discovery and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials